trans-11-Chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
- Catalog No. :
- ACXTLD615
- CAS No. :
- 129385-59-7
- Molecular Formula :
- C17H14ClNO2
- Molecular Weight :
- 299.76
IUPAC Name:(3aS,12bS)-11-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g97%$56.00Login to see priceIn stockInquiry
25g97%$121.00Login to see priceIn stockInquiry
100g97%$387.00Login to see priceInquiryInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | trans-11-Chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
|---|---|
| IUPAC Name | (3aS,12bS)-11-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
| MDL No. | MFCD15145474 |
| Molecular Formula | C17H14ClNO2 |
| Molecular Weight | 299.76 |
| SMILES | O=C1N(C)C[C@@]2([H])[C@@]1([H])C3=CC(Cl)=CC=C3OC4=CC=CC=C42 |
| InChI Key | OOUVAHYYJVOIIB-CZUORRHYSA-N |
| Synonym | (3aR,12bR)-11-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrol-1-one;trans-11-Chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrol-1-one;trans-(+/-)-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one;1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one,11-chloro-2,3,3a,12b-tetrahydro-2-methyl-, (3aR,12bR)-rel-;cis-trans Mixture-11-Chloro-2,3,3a,12b-tetrahydro-2-Methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one;Asenapine pharMaceutical interMediate;Trans-(+/-)-11-Chloro-2,3,3a,12b-tetrahydro-2-Methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole-1-one;trans-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz-[2,3:6,7]-oxepino-[4,5-c]-pyrrol-1-one (asenapine base) |
| CAS No. | 129385-59-7 |
| PubChem CID | 54753299 |
Safety Data
- Pictogram
- Signal Word
- Warning
- Hazard Statement(s)
- H302-H315-H319-H335
- Precautionary Statement(s)
- P261-P305+P351+P338

